[Gonadotropic and steroid hormone excretion during 17-oxyprogesterone caproate therapy of primary endometrial cancer].
D000328:Adult; D000368:Aged; D002208:Caproates / Q000627:therapeutic use; D004715:Endometriosis / Q000188:drug therapy*; D004967:Estrogens / Q000652:urine*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006065:Gonadotropins, Pituitary / Q000652:urine*; D006801:Humans; D008599:Menstruation Disturbances / Q000209:etiology; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests; D011374:Progesterone / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D002208:Caproates; D004967:Estrogens; D006065:Gonadotropins, Pituitary; D011374:Progesterone; D005640:Follicle Stimulating Hormone
Eksretsiia gonadotropnykh i steroidnykh gormonov pri lechenii pervichnogo raka endometriia 17-oksiprogesteron-kapronatom.